These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32787225)

  • 21. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.
    Lubinski B; Frazier LE; Phan MVT; Bugembe DL; Cunningham JL; Tang T; Daniel S; Cotten M; Jaimes JA; Whittaker GR
    Microbiol Spectr; 2022 Aug; 10(4):e0151422. PubMed ID: 35766497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sequence at Spike S1/S2 site enables cleavage by furin and phospho-regulation in SARS-CoV2 but not in SARS-CoV1 or MERS-CoV.
    Örd M; Faustova I; Loog M
    Sci Rep; 2020 Oct; 10(1):16944. PubMed ID: 33037310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.
    Mjokane N; Maliehe M; Folorunso OS; Ogundeji AO; Gcilitshana OMN; Albertyn J; Pohl CH; Sebolai OM
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination.
    Hossain MG; Tang YD; Akter S; Zheng C
    J Med Virol; 2022 May; 94(5):1815-1820. PubMed ID: 34936124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptococcal proteases exhibit the potential to activate the latent SARS-CoV-2 spike protein.
    Mjokane N; Sabiu S; Folorunso OS; Gcilitshana OMN; Albertyn J; Pohl CH; Sebolai OM
    J Infect Public Health; 2024 Feb; 17(2):263-270. PubMed ID: 38128410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
    Bestle D; Heindl MR; Limburg H; Van Lam van T; Pilgram O; Moulton H; Stein DA; Hardes K; Eickmann M; Dolnik O; Rohde C; Klenk HD; Garten W; Steinmetzer T; Böttcher-Friebertshäuser E
    Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32703818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight towards the effect of the multi basic cleavage site of SARS-CoV-2 spike protein on cellular proteases.
    Shokeen K; Pandey S; Shah M; Kumar S
    Virus Res; 2022 Sep; 318():198845. PubMed ID: 35680004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
    Minami S; Kotaki T; Sakai Y; Okamura S; Torii S; Ono C; Motooka D; Hamajima R; Nouda R; Nurdin JA; Yamasaki M; Kanai Y; Ebina H; Maeda Y; Okamoto T; Tachibana T; Matsuura Y; Kobayashi T
    Microbiol Spectr; 2024 Apr; 12(4):e0285923. PubMed ID: 38415690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.
    Gobeil SM; Janowska K; McDowell S; Mansouri K; Parks R; Manne K; Stalls V; Kopp MF; Henderson R; Edwards RJ; Haynes BF; Acharya P
    Cell Rep; 2021 Jan; 34(2):108630. PubMed ID: 33417835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity.
    Wang S; Ran W; Sun L; Fan Q; Zhao Y; Wang B; Yang J; He Y; Wu Y; Wang Y; Chen L; Chuchuay A; You Y; Zhu X; Wang X; Chen Y; Wang Y; Chen YQ; Yuan Y; Zhao J; Mao Y
    Nat Commun; 2024 May; 15(1):4162. PubMed ID: 38755139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.
    Cheng YW; Chao TL; Li CL; Chiu MF; Kao HC; Wang SH; Pang YH; Lin CH; Tsai YM; Lee WH; Tao MH; Ho TC; Wu PY; Jang LT; Chen PJ; Chang SY; Yeh SH
    Cell Rep; 2020 Oct; 33(2):108254. PubMed ID: 33007239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.
    Reuter N; Chen X; Kropff B; Peter AS; Britt WJ; Mach M; Überla K; Thomas M
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.
    Bollavaram K; Leeman TH; Lee MW; Kulkarni A; Upshaw SG; Yang J; Song H; Platt MO
    Protein Sci; 2021 Jun; 30(6):1131-1143. PubMed ID: 33786919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropilin-1 is a host factor for SARS-CoV-2 infection.
    Daly JL; Simonetti B; Klein K; Chen KE; Williamson MK; Antón-Plágaro C; Shoemark DK; Simón-Gracia L; Bauer M; Hollandi R; Greber UF; Horvath P; Sessions RB; Helenius A; Hiscox JA; Teesalu T; Matthews DA; Davidson AD; Collins BM; Cullen PJ; Yamauchi Y
    Science; 2020 Nov; 370(6518):861-865. PubMed ID: 33082294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics.
    Jiang X; Li D; Maghsoudloo M; Zhang X; Ma W; Fu J
    Drug Discov Today; 2024 Jul; 29(7):104026. PubMed ID: 38762086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.
    Papa G; Mallery DL; Albecka A; Welch LG; Cattin-Ortolá J; Luptak J; Paul D; McMahon HT; Goodfellow IG; Carter A; Munro S; James LC
    PLoS Pathog; 2021 Jan; 17(1):e1009246. PubMed ID: 33493182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.